Skip to content

Socioeconomic Aspects Before and After Radiation Therapy in Patient With Prostate Cancer

Evaluation of Socioeconomic Aspects Before and After Primary Radiation Therapy (Percutaneous or Interstitial or Combined Percutaneous and Interstitial) in Patients With Prostate Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01849471
Acronym
ECOPRO
Enrollment
60
Registered
2013-05-08
Start date
2013-04-30
Completion date
2019-05-31
Last updated
2016-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

socioeconomic aspects, costs of therapy, follow-up costs, primary radiation, percutaneous, interstitial

Brief summary

This trial is an interrogation of patients with prostate cancer to evaluate socioeconomic effects of radiotherapy. Patients with percutaneous or interstitial or combined percutaneous and interstitial radiotherapy are included. Beside medical effects and adverse events, it's prospectively needed to extensively inform patients about socioeconomic aspects associated with radiotherapy. The interrogation comprises to collect possible costs and expenditures during and after therapy. Aspects especially concerning post therapy period include additional consultations, individual applied alternative medical care, need for additional medical aids (salves, medicine, bandages) and changes in professional and social situation. It's figured out in what extend costs are absorbed by health insurance coverage. In Germany there is no appropriate trial with respective patient population and respective therapy. Primary endpoint is the evaluation of therapy concerning and follow-up costs as well as changes in social and professional situation. Secondary endpoints are quality of life, adverse events of therapy and the correlation of quality of life, adverse events and economic aspects for the patient and the health insurance coverage.

Interventions

OTHERquestionnaires

patients receive questionnaires regarding socioeconomic aspects before, during and after therapy

Sponsors

University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* minimal age 18 * low, mediate and high-grade prostate cancer

Exclusion criteria

* tumor recurrence * surgery as primary therapy * prior radiotherapy except conventional radiotherapy * patients with other malignancies

Design outcomes

Primary

MeasureTime frameDescription
therapy concerning and follow-up costs associated with changes in social professional situation that is connected with Quality of lifeParticipants will be followed for the duration of therapy and for 1 year after the last study treatmentby questionnaires concerning social aspects and quality of life to evaluate connections between these parameters

Secondary

MeasureTime frame
adverse eventsParticipants will be followed for the duration of therapy and for 1 year after the last study treatment
correlation of quality of life, adverse events and economic aspects for the patient and the health insurance coverageParticipants will be followed for the duration of therapy and for 1 year after the last study treatment

Countries

Germany

Contacts

Primary ContactAnnedore Strnad, MD, MHBA
annedore.strnad@uk.erlangen.de++49(0)9131 85
Backup ContactRainer Fietkau, MD
st-studiensekretariat@uk-erlangen.de++49(0)9131 85

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026